newsfilter
← Latest News
GlobeNewswire·

Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026

Results from prespecified assessment of End of Progression™ in the RAPIDe-3 Phase 3 study and clinical relevance of this newly-defined endpoint detailed in an oral presentationEvidence on the cardiovascular safety